This African cultivator has the largest licensed footprint in the region, specializing in high-THC and low-cost cannabis production. With GACP, IMC-GAP, and CUMCS certifications, and supported by a South African and U.S.-based ownership group, this cultivator is set to thrive globally in the cannabis market.
Listing Highlights:
- Established, high-margin cultivator and exporter of premium medical THC flower with exponential growth potential.
- Africa’s first large-scale exporter of medical cannabis, strategically positioned to support global demand for innovative, high-quality strains.
- Managed by an experienced South African and U.S.-based group, offering industry-low overhead and tax benefits.
- Engaged in comprehensive cannabis operations: cultivation, genetics/tissue culture, trimming, drying, propagation, B2B sales, and exports to Israel.
- Owns Africa’s largest medical cannabis cultivation license, operating an advanced 80,000 sq. ft. greenhouse on 370 acres, with a 10,000 kg annual production capacity.
- Newly constructed ~8,500 sq. ft. post-harvest EU GMP-ready facility.
- Four premium cultivars with THC levels of 22-24.5% are fully developed, with active efforts underway to cultivate additional unique strains.
- Active purchase discussions and commercial leads in Australia, Germany, Poland, and South Africa.
- Expansive footprint: License can support up to 30 greenhouses and extensive outdoor cultivation.
- EU GMP certification targeted within 18 months; strategic partnership could accelerate this timeline.
Strategic Opportunity:
Partnering with Africa’s leading cannabis cultivator offers a unique chance to secure a strong position within the global cannabis supply chain. Leveraging state-of-the-art facilities, an attractive labor dynamic, and a pro-business, pro-cannabis government, this investment promises high returns with an expansive market reach.